Anagliptin

安奈格列汀

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAnagliptin
Drug Alias Nameanagliptinum阿那格列汀anagliptina阿拉格列汀anagliptine +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2012/09/28
Country/TerritoryUnited StatesSouth KoreaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanwa Kagaku Kenkyusho Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJw Pharmaceutical CorpKowa Research Institute IncSanwa Kagaku Kenkyusho Co Ltd
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BH
Related LinksWikipediaDrugBankKEGG